Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Hematologic Diseases × Midazolam × 30 days × Clear all

Sponsor

Conditions

Urothelial Cancer 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Opioid-Related Disorders 1 Neoplasms 1 Leiomyosarcoma 1 KRAS p.G12C Mutant Advanced Solid Tumors 1 Cancer Pain 1 Advanced Malignancies 1

Interventions

pirtobrutinib 2 ibrutinib 2 fludarabine phosphate 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Cyclophosphamide 2 Bone Marrow Transplantation 2 Azacitidine 2 venetoclax 1 ponatinib 1 pembrolizumab 1 fludarabine 1 cedazuridine 1 Whole-Body Irradiation 1 Tacrolimus 1 Quality of Life 1 Peripheral Blood Stem Cell Transplantation 1 Patient Reported Outcome Measures 1 Filgrastim 1 Electrocardiography 1 Clinical Laboratory Techniques 1 Busulfan 1 Bone Marrow Examination 1 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡